Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Challenges & Collaborative Efforts with Pharma Companies
Unintentional Drug Poisoning Deaths, Michigan Residents, 1999-2009 Su Min Oh, PhD Michigan Department of Community Health Bureau of Substance Abuse and.
Increased Risk of Hepatic Decompensation in HIV/HCV-Coinfected Versus HCV-Monoinfected Patients Despite ART Vincent Lo Re, MD, MSCE J Tate, MJ Kallan,
PLACE DU SCORE DE PROPENSION EN EPIDEMIOLOGIE CLINIQUE Christophe Clec’h Présentation IAB, 21 Décembre 2007 Présentation IAB, 21 Décembre 2007.
Farmacovigilanza nell’anziano fragile Gianluca Trifirò Università di Messina Erasmus University Medical Center, Rotterdam (Olanda)
Uso adecuado de los psicofarmacos
Pharmaceutical industry – change in discovery and development
Role of health plans 1 peter currie
Nsaids and cvs risk
Other Major Side Effects to Immunomodulators and/or Biologics in Our IBD Patients Edward V. Loftus, Jr., M.D. Professor of Medicine Mayo Clinic Rochester,
International Conference on Hematology & Blood Disorders Track 9: thrombosis & haemostasia Antipsychotics & venous thromboembolism disease: the great unknow.
1 2 Why should I lose time to send a report of adverse drug reactions?
